World's Best Scientists 2026 revealed!
Jan Cools

Jan Cools

D-Index & Metrics

Medicine

D-Index
79
Citations
25906
World Ranking
17460
National Ranking
220

Jan Cools publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jan Cools sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 368 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jan Cools D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jan Cools sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jan Cools is affiliated with KU Leuven in Belgium and has made significant contributions to the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their research primarily focuses on molecular biology, public health, environmental and occupational health, hematology, immunology, and cancer research.

The scientist's research topics highlight a strong concentration in leukemia and lymphoma studies, including acute lymphoblastic leukemia research, acute myeloid leukemia research, lymphoma diagnosis and treatment, CAR-T cell therapy research, chronic myeloid leukemia treatments, epigenetics and DNA methylation, as well as cancer genomics and diagnostics.

Jan Cools has published extensively, with recent notable papers including:

  • PHGDH heterogeneity potentiates cancer cell dissemination and metastasis, 2022, Nature
  • A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling, 2023, Nature Cancer
  • Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia, 2020, Blood
  • Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping, 2022, American Journal of Hematology
  • Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma, 2021, Blood

The scientist frequently publishes in journals such as Blood and HemaSphere, with ten publications each, as well as in bioRxiv (Cold Spring Harbor Laboratory), Haematologica, and Nature. This reflects a broad engagement with hematology and molecular biology-oriented scientific venues.

Collaboration is also a significant aspect of their research activity. Frequent co-authors include Sofie Demeyer, Olga Gielen, Heidi Segers, Nicole Mentens, and Kris Jacobs, indicating a network focused on related biomedical and hematological research.

Best Publications

  • Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

    Ross L. Levine;Ross L. Levine;Martha Wadleigh;Jan Cools;Benjamin L. Ebert;Benjamin L. Ebert

  • A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

    Jan Cools;Jan Cools;Daniel J. DeAngelo;Jason Gotlib;Elizabeth H. Stover

  • The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

    Jinghui Zhang;Li Ding;Linda Holmfeldt;Gang Wu

  • Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia

    Pieter Peeters;Sophie D. Raynaud;Jan Cools;Iwona Wlodarska

  • Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

    Maria Debiec-Rychter;Jan Cools;Herlinde Dumez;Raf Sciot

  • Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.

    Hilde Brems;Magdalena Chmara;Magdalena Chmara;Mourad Sahbatou;Ellen Denayer

  • Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.

    Amy D. Klion;Amy D. Klion;Pierre Noel;Pierre Noel;Cem Akin;Cem Akin;Melissa A. Law;Melissa A. Law

  • Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

    C Graux;Jan Cools;C Melotte;H Quentmeier

  • Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia

    Kim De Keersmaecker;Zeynep Kalender Atak;Ning Li;Carmen Vicente

  • CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

    Animesh Pardanani;Animesh Pardanani;Animesh Pardanani;Rhett P. Ketterling;Rhett P. Ketterling;Rhett P. Ketterling;Stephanie R. Brockman;Stephanie R. Brockman;Stephanie R. Brockman;Heather C. Flynn;Heather C. Flynn;Heather C. Flynn

  • The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management

    Jason Gotlib;Jason Gotlib;Jason Gotlib;Jan Cools;Jan Cools;Jan Cools;James M. Malone;James M. Malone;James M. Malone;Stanley L. Schrier;Stanley L. Schrier;Stanley L. Schrier

  • Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate.

    Hans Prenen;Jan Cools;Nicole Mentens;Cedric Folens

  • Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast.

    Carlos Graux;Jan Cools;Lucienne Michaux;Peter Vandenberghe

  • The genetics and molecular biology of T-ALL

    Tiziana Girardi;Carmen Vicente;Carmen Vicente;Jan Cools;Jan Cools;Kim De Keersmaecker

  • Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.

    Jan Cools;Iwona Wlodarska;Riet Somers;Nicole Mentens

  • Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

    Sara De Brouwer;Katleen De Preter;Candy Kumps;Piotr Zabrocki

  • Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia

    Idoya Lahortiga;Kim De Keersmaecker;Kim De Keersmaecker;Pieter Van Vlierberghe;Carlos Graux;Carlos Graux;Carlos Graux

  • PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.

    Jan Cools;Elizabeth H Stover;Christina L Boulton;Christina L Boulton;Jason Gotlib

  • The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia

    Pieter Van Vlierberghe;Martine van Grotel;Joëlle Tchinda;Charles Lee

  • Duplication of the MYB oncogene in T-cell acute lymphoblastic leukemia

    Idoya Lahortiga;Kim De Keersmaecker;Pieter Van Vlierberghe;C. Graux

Frequent Co-Authors

Peter Marynen
Peter Marynen KU Leuven
Stein Aerts
Stein Aerts KU Leuven
Franki Speleman
Franki Speleman Ghent University
D. Gary Gilliland
D. Gary Gilliland Fred Hutchinson Cancer Research Center
Tom Taghon
Tom Taghon Ghent University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t have to follow a traditional path. Many students begin by pursuing alternative healthcare degrees or certifications online. For example, becoming a nurse can be more attainable by applying to the easiest bsn program to get into, which offers flexible admissions and a smoother route for those starting their healthcare journey.

Other in-demand options include medical billing and coding, which provide stable career opportunities with less time commitment than a full medical degree. There are online medical billing and coding schools that accept fafsa, making quality training both accessible and affordable to more students.

Additionally, if you want to work in nursing but wish to avoid certain testing barriers, you can consider nursing programs without teas exams, which streamline the entry process for prospective nurses.

For those interested in the administrative side of healthcare, accelerated healthcare programs are also available online, allowing you to complete your studies in less time and enter the workforce quickly.

Best Scientists Citing Jan Cools

Trending Scientists

Recently Published Articles